PELP1, EGR-1 and ERRα as potential targets for new therapies against adrenocortical carcinoma
A De Luca, S Andò, V Pezzi - 2019 - dspace.unical.it
… (G protein-coupled estrogen receptor 1) ha ridotto la crescita tumorale in … Gemcitabine
alone or in combination with mitotane … of mTOR in combination with cixutumumab, an anti-IGF-R1 …
alone or in combination with mitotane … of mTOR in combination with cixutumumab, an anti-IGF-R1 …
[PDF][PDF] PARTLY BASED ON
SG Creemers, LJ Hofland, SW Lamberts… - Novel Insights into …, 2019 - repub.eur.nl
… -EDP are gemcitabine with or … growth factor receptor (IGF-1R) antibody cixutumumab
combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma…
combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma…
Molecular biomarkers and treatment outcomes in advanced genitourinary malignancies
JM Lavoie - 2019 - open.library.ubc.ca
… growth factor receptor (EGFR) inhibitor erlotinib in combination with gemcitabine (73), or
the insulin-like growth factor type 1 receptor (IGF1R) antibody cixutumumab (74) or inhibitor …
the insulin-like growth factor type 1 receptor (IGF1R) antibody cixutumumab (74) or inhibitor …
[HTML][HTML] Adrenal cancer
JF Torti, R Correa - 2019 - europepmc.org
… metastatic lesions due to direct infiltration by adjacent cancer or … of erlotinib and gemcitabine.
Among vascular endothelial … ACC patients received cixutumumab with temsirolimus, an …
Among vascular endothelial … ACC patients received cixutumumab with temsirolimus, an …
[图书][B] Onkolojide Moleküler Hedefli Tedaviler
AM SEDEF - 2020 - books.google.com
… growth factor receptor-1 (VEGFR-1) targeting in cancer cells … Erlotinib plus gemcitabine
compared with gemcitabine alone … metastatic colorectal cancer (CONCUR): a randomised, …
compared with gemcitabine alone … metastatic colorectal cancer (CONCUR): a randomised, …